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Abstract
Introduction and hypotheses There is no consensus regarding pregnancy after mid-urethral sling (MUS) operation, and some
clinicians recommend postponing the MUS operation if a woman considers further pregnancies or routinely suggest cesarean
section as the delivery method after MUS operations. Our primary aim was to assess the risk for stress urinary incontinence (SUI)
re-procedure after delivery in women with aMUS operation prior to pregnancy.We also analyzed SUI re-visits andMUS-related
complications during pregnancy and postpartum.
Methods We conducted a register-based case-control study of women with a MUS operation in Finland during 1996–2016. We
identified 94 cases with a subsequent pregnancy and 330 controls without subsequent pregnancies matched by age, operation
type and year.
Results The median follow-up time was 10.7 years (IQR 7.1–13.7). The number of SUI re-procedures did not differ between the
cases (n = 3, 3.2%) and controls (n = 17, 5.2%; OR 0.6, 95%CI 0.2–2.1). There was no significant difference in re-visits for stress
or mixed urinary incontinence between the cases (n = 23, 24.5%) and controls (n = 86, 26.1%; OR 0.9, 95%CI 0.5–1.6), but 35%
of the re-visits in the case group occurred already before the delivery after MUS. The rate of vaginal delivery was lower after
MUS operation (57%) than in deliveries before MUS (91%, P < 0.001).
Conclusions Pregnancy after MUS did not increase the odds for SUI re-procedure or re-visit. Considering on our results, future
pregnancy does not need to be viewed as an absolute contraindication for MUS operation.
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Introduction
Stress urinary incontinence (SUI) is a common disorder in
women. Approximately 10–14% of women will have an
operation for SUI during their lifetime [1, 2], and the mid-
urethral sling (MUS) is considered the gold standard surgical
treatment for SUI.Women are commonly advised to postpone
surgical treatment for SUI until childbearing has been com-
pleted [3] because of the fear of SUI relapse or complications
during pregnancy or delivery [3]. It has also been commonly
recommended that cesarean section should be the mode of
delivery after a MUS operation [4]. Thus, SUI operations are
relatively uncommon among women younger than 40, even
though the prevalence of severe SUI is around 10% among
women between 25 and 49 years of age [1, 5].
There is no guideline or clinical consensus concerning the
MUS operation and future pregnancies. Only in two cohort
studies and smaller case series has pregnancy after MUS op-
eration been assessed showing that pregnancy after MUS did
not increase the risk for SUI relapse or SUI re-operation [10,
11].
In our register-based case-control cohort study, we
assessed the incidence of urinary incontinence and re-
operation for SUI in women with a previous MUS operation.
We also report the number of potentially MUS-related
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complications during pregnancy and postpartum subsequent
to a MUS operation.
Materials and methods
We conducted a case-control study of women who had a
retropubic (RP-MUS) or transobturator mid-urethral sling
(TO-MUS, including inside-out TVT-O and outside-in TOT)
operation in Finland between 1996 and 2016. As cases, we
identified all women who had had a pregnancy ending in
delivery after the index operation, and for each case, we se-
lected up to four controls without subsequent deliveries.
Controls were matched with cases by age (± 2 years), MUS
type (retropubic vs. transobturator) and MUS operation year
(± 2 years). The follow-up continued until the end of 2017.
The cases and their controls were identified by linking two
national registers: the Care Register for Health Care (Care
Register), in which all health care providing institutes in
Finland are required by law to report all their specialized med-
icine patient visits, and the Medical Birth Register, in which
all deliveries in Finland are recorded including information on
the delivery, the delivered babies and their mothers (Fig. 1).
We identified the sample by searching all visits with the
Nordic Medico-Statistical Committee Classification of
Surgical Procedures (NCSP) operation codes for MUS oper-
ation (LEG10 for retropubic MUS, LEG12 for outside-in
transobturator MUS and LEG13 for inside-out transobturator
MUS). Then, women with a delivery after the MUS operation
were identified by a search of the Medical Birth Register.
From the remaining women without a subsequent delivery,
up to four matched controls per each case were randomly
selected. The preoperative incontinence type for the sample
women was considered as SUI if the ICD-10 diagnosis code
for the operation was N93.3, mixed urinary incontinence
(MUI) if it was N39.4 and unknown if any other diagnosis
code was used.
As cases, we identified 99 women who had a MUS proce-
dure from 1995 to 2016 and a subsequent pregnancy ending in
delivery (Fig. 1). Two of them were excluded from further
analysis because they had the MUS procedure for hypospadi-
as, and they were younger than 18 during the time of the
procedure. Another three were excluded from further analysis
because they had a SUI re-operation between the index MUS
and the subsequent pregnancy. Thus, the case group consisted
of 94 women. We identified 330 matched controls who had a
MUS procedure from 1995 to 2016 but no subsequent preg-
nancies. Due to the matching criteria, fewer than four controls
were available for some cases: the number of identified
matching controls was 4 for 78 cases, 3 for 2 cases, 2 for 4
cases, 1 for 4 cases and 0 for 6 cases. Due to the selection
criteria of age andMUS type, we did not have enough controls
in the database to select from.
New incontinence visits and re-procedures were identified
from the Care Register and Register of Primary Health Care
visits (Register of PHC) by using appropriate ICD-10 codes
for urinary incontinence and NCSP codes for SUI procedures
(ICD-10 codes for SUI re-visit: stress urinary incontinence
N39.3 and mixed urinary incontinence N39.4, NCSP codes
for SUI re-procedure; see Supporting Information Table S1).
All public health care-providing institutes in Finland are re-
quired by law to report admission and discharge dates, and all
diagnosis and procedure codes of all in- and out-patient visits.
Visits in specialized medicine are reported to the Care
Register, and visits in general medicine are reported to the
Register of PHC. Therefore, our data include all incontinence
visits and re-procedures performed in the public sector in
Finland. Of all MUS procedures in Finland, 98.4% were per-
formed in the public sector during our study period (Finnish
Institute for Health andWelfare). Visits within the first 60 days
after the index operation were considered control visits and
were not included in the analysis.
Pregnancy and post-partum complications were identified
from the Care Register, the Register of PHC and the Medical
Birth register. We identified all visits from 315 days before to
42 days after the postoperative delivery from the Care
Register and the Register of PHC and considered them as
complications if the visit included the diagnostic code for
urinary incontinence, urinary tract infection, erosion, abdom-
inal or pelvic or perineal pain, acute pain, urinary retention,
dysuria, pollakiuria, other difficulties to urinate and perineal
lacerations during vaginal delivery (see Supporting
Information Table S2 for the detailed list of ICD-10 diagnostic
codes and NCSP-codes used). We also identified visits for
SUI and MUI for women who had not had previous visits
for incontinence between the index operation and the postop-
erative pregnancy.
The main outcome was new SUI procedures, which were
defined as a visit recorded in the Care Register with a NCSP
code for MUS, urethral bulking injection, colposuspension or
bladder neck needle suspension (see the detailed NCSP codes
used in Supporting Information Table S1). Secondary out-
comes were re-visits for SUI orMUI after the index operation,
the effect of the delivery mode on the risk for a new SUI
procedure and complications during pregnancies and post-
partum after MUS operation defined as diagnostic codes re-
ported in the Medical Birth Register as illnesses during
pregnancy.
The treatment of SUI in Finland follows the National
Guideline [6]. The first-line treatment options for SUI are
conservative, including pelvic floor muscle training, but oper-
ative treatment is indicated if conservative treatment fails. The
first-line operative treatment option has beenMUS, especially
RP-MUS, since the late 1990s. Other operations, such as
Burch colposuspension, have been seldom used [1].
National MUS practices are uniform because of a structured
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training program when RP-MUS was first introduced [7]. By
the end of 1999 in Finland, MUS operations were performed
in 40 hospitals [7], and by 2018 they were performed in 25
public hospitals (Finnish Institute for Health and Welfare).
BM SPSS Statistics 25 was used for statistical analysis. To
compare groups, we used the Student’s t-test for continuous
variables and chi-squared or Fisher’s exact test, when appro-
priate, for categorical variables. To calculate confidence inter-
vals, we used Clopper-Pearson for binomial variables and
Student’s t-test for continuous variables. We used the odds
ratio and Cox regression to analyze risk factors for a new
SUI procedure.
The Finnish Institute for Health and Welfare of Finland
authorized the use of the data from the Care Register, the
Medical Birth Register and the Register for PHC (THL/945/
5.05.00/2017). The register authorities assessed the ethics of
the study, and as no contact with the subjects was included,
the study was exempted from evaluation by an Ethics
Committee.
Results
In our study population RP-MUS was more common than
TO-MUS (Table 1). The only demographic difference be-
tween the groups was parity; the case women were more often
both primiparas and multiparas (3 or more deliveries) than the
control women (P < 0.001). The median follow-up time was
10.7 years (IQR 7.1–13.7).
Fig. 1 Flowchart of sampling process
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New SUI procedures were performed in 3 cases (3.2%) and
on 17 controls (5.2%, Table 2). There was no difference in the
number of new procedures for SUI between the cases and
controls (P = 0.6) or the median time between the index
MUS and the re-procedure (4.4 and 4.6 years, respectively,
P = 1.0). None of the tested variables (subsequent pregnancy,
incontinence type, operation type and parity) affected the risk
for SUI re-procedure (Table 3). Of the three cases who had a
SUI re-procedure, two had a vaginal delivery and one had an
elective cesarean section.
Re-visits for SUI and MUI were equally common in the
case group (n = 23, 25%) and control group (n = 86, 26%; OR
0.9, 95% CI 0.5–1.6) (Table 2). Among the cases, 63% of the
re-visits (n = 15) occurred already before pregnancy. In both
the case and control groups, the majority (61% and 66%) of
the re-visits were due to SUI.
Of the 94 first deliveries after MUS, 54 (57%) were
vaginal deliveries, 24 (26%) were elective cesarean sec-
tions, and 16 (17%) were urgent or crash cesarean sec-
tions. The number of elective cesarean sections was
Table 1 Sample demographics
Cases (94) Controls (330) P
Incontinence type, n (%) 0.5
SUI 81 (86) 267 (81)
MUI 5 (5) 23 (7)
Unknown or other 8 (9) 40 (12)
Index operation, n (%) 1.0
RP-MUS 61 (65) 213 (65)
TO-MUS 33 (35) 117 (35)
Age at index operation, median (IQR) 35 (32–38) 36 (33–38) 0.08
Parity before index operation, n (%) < 0.001
0 9 (10) 13 (4)
1–2 57 (61) 279 (85)
3 or more 28 (30) 38 (12)
Index operation year, n (%) 0.08
1997–1999 2 (2) 0 (0)
2000–2004 29 (31) 98 (30)
2005–2009 36 (38) 133 (40)
2010–2014 26 (28) 89 (27)
2015–2016 1 (1) 10 (3)
BMI at start of last pregnancy before index MUS 0.9
Median (IQR) 23 (21–25) 23 (21–26)
Unknown, n (%) 63 (70) 217 (66)
Follow-up time, median in years (IQR) 10.8 (7.2–13.9) 10.6 (7.1–13.7)
Mode of deliveries before index operation, n (%) 0.1
Only vaginal 77 (91) 280 (88)
One or more cesarean sections 8 (9) 31 (10)
Unknown 0 (0) 6 (2)
Number of deliveries after index MUS
1 85 (90) –
2 9 (10) –
Mode of delivery after index operation, n (%)
Vaginal 54 (57) –
Elective cesarean section 24 (26) –
Urgent or emergency cesarean section 16 (17) –
Difference compared with delivery mode before index operation < 0.001
Time to delivery after index MUS, median in years (IQR) 2.6 (1.6–4.6) – 0.7
SUI = stress urinary incontinence, MUI =mixed urinary incontinence, RP-MUS= retropubic mid-urethral sling,
TO-MUS= transobturator mid-urethral sling, BMI = body mass index, MUS =mid-urethral sling
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significantly higher in women with MUS operation prior
to pregnancy compared with their last delivery before the
MUS operation (P < 0.001). The proportion of cesarean
sections did not vary during the follow-up period. Nine
case women had two deliveries after MUS; none of them
had SUI re-operations.
During the pregnancy or postpartum after MUS, 18 cases
(18.6%) had a visit for urinary tract infection, urinary
Table 3 Risk factor analysis for
stress urinary incontinence re-
procedure after mid-urethral sling
operation
Univariate analysis HR 95% CI, P = 0.05 P
Postoperative delivery 0.4
No deliveries 1 (ref)
Postoperative delivery 0.6 0.2 2.1
Incontinence type 0.2
SUI 1 (ref)
MUI or other 1.9 0.7 4.9
Operation type 1.0
RP-MUS 1 (ref)
TO-MUS 1.0 0.4 2.6
Parity before index operation 0.2
Nulliparous 1 (ref)
1–2 deliveries 0.5 0.1 2.1
3 or more deliveries 0.1 0.01 1.6
Multivariate analysis HR 95% CI, P = 0.05 P
Postoperative delivery adj. with incontinence type and parity 0.3
MUI or other (ref: SUI) 2.0 0.7 5.3
1–2 deliveries (ref: nulliparous) 0.4 0.1 2.3
3 or more deliveries (ref: nulliparous) 0.1 0.01 1.6
Postoperative delivery (ref: no delivery) 1.5 0.4 5.4
SUI = stress urinary incontinence, MUI =mixed urinary incontinence, RP-MUS= retropubic mid-urethral sling
TO-MUS= transobturator mid-urethral sling, HR = hazard ratio
Table 2 Re-procedures and re-visits for stress urinary incontinence after mid-urethral operation
Cases (94) Controls (330) OR (95% CI) P
SUI re-procedure, n (%) 3 (3.2) 17 (5.2) 0.6 (0.2–2.1) 0.6
RP-MUS 1 (33.3) 9 (52.9)
TO-MUS 0 4 (23.5)
Bulking injection 2 (66.7) 3 (17.6)
Other vaginal operation 0 1 (5.9)
Re-procedures between index MUS and subsequent delivery included 6 (6.2) 17 (5.0) 1.2 (0.5–3.3) 0.6
Time to re-operation, median in years (IQR) 4.4 (2.7-NA) 4.6 (2.3–7.6) 0.5
SUI or MUI re-visit, n (%) 23 (24.5) 86 (26.1) 0.9 (0.5–1.6) 1.0
Re-visits between index MUS and subsequent delivery 15 (65.2) –
Re-visit incontinence type
SUI 14 (60.9) 57 (66.3)
MUI 9 (39.1) 29 (33.7)
Time to re-visit, median in years (IQR) 2.6 (0.0–6.0) 0.7 (0.0–3.0) 0.04
SUI = stress urinary incontinence, MUI =mixed urinary incontinence, RP-MUS = retropubic mid-urethral sling, TO-MUS= transobturator mid-urethral
sling, MUS =mid-urethral sling
Int Urogynecol J
incontinence, or pelvic or perineal or lower abdominal pain
(Table 4). There were no visits for urinary retention or other
urinary symptoms or erosion.
Discussion
We show that in women who had a pregnancy ending in
delivery after a MUS operation, the rate of SUI re-
procedures did not differ from that of controls without a sub-
sequent pregnancy (3.2% vs. 5.2%, respectively, P = 0.6).
This result is in line with previous studies [10, 11]. The long
follow-up time, median 10.7 years, assured that we were able
to find the majority of the re-procedures, since they mostly
took place within the first postoperative years [8, 9]. The me-
dian time from MUS to childbirth was 2.6 years, and thus the
follow-up was still long enough to show most of the relapses.
In previous studies assessing the effect of childbirth after
MUS, the rate (18% and 22%) [10, 11] of women with symp-
tomatic SUI are in line with the number of re-visits in our
study. This, at least in part, may reflect the rate of various
SUI symptoms. In a previous study, the SUI re-procedure rate
was assessed as a secondary outcome, and this number (5.6%)
is also comparable with our findings [11]. The original MUS
operations were developed and studied in a Nordic co-work
[12], and thus it is likely that similar technique and indications
in the Nordic countries explain the comparable results.
However, smaller case series from other countries also show
MUS to be effective after subsequent childbirth [13–15].
We show that delivery after MUS was not a significant risk
factor for SUI relapse, being in line with previous studies [10,
11]. However, the end point in our study was a SUI re-
procedure or re-visit instead of subjective cure after the
follow-up measured by questionnaires. In contrast, we were
able to evaluate the exact timing of SUI relapses and identify
those that occurred before the subsequent pregnancy.
The analysis of secondary end points, complications of
MUS during pregnancy, delivery or post-partum period
showed no urinary retention or dysuria. The number of urinary
tract infections during pregnancy and post-partum was also
low (4%), and no recurrent urinary tract infections were found.
In previous studies, a relatively low 1.4% de novo voiding
dysfunction needing intermittent catheterization was detected,
and 2.8% reported recurrent urinary tract infections [11].
These numbers are reassuring, showing that MUS does not
cause high risk for urinary tract symptoms during pregnancy
and post-partum. However, 12 women (13%) in our case
group had visits during pregnancy or post-partum because of
pain in the abdomen or perineum. We were unable to assess
whether these visits for pain were directly MUS related and
whether the pain was later resolved. Other studies have not
reported chronic pelvic pain [11], but further studies are need-
ed since pain is one of the major concerns associated with
MUS use.
There is no consensus on the mode of delivery in women
with a previous MUS operation, and many doctors have rec-
ommended cesarean section in fear of recurrent SUI after vag-
inal delivery [4]. Even though we could not assess the reasons
for choosing the delivery mode, it is likely that MUS has been
an indication for some cesarean sections since elective cesar-
ean sections were significantly more frequent after the MUS
operation, even though 82% of parous case women had only
vaginal deliveries before the indexMUS. The total section rate
after MUS in our data was 42%, which is lower (58% and
54%) than in previous studies [10, 11]. Although up to 77% of
women in a previous study [10] reported that MUS was an
Table 4 Complications during
pregnancy and post-partum after
mid-urethral sling operation
Complication, n (%) Pregnancy Postpartum
Incontinence 4 (4) 0 (0)
Stress urinary incontinence 3 (3) 0 (0)
Mixed urinary incontinence 1 (1) 0 (0)
Urinary tract infection 2 (2) 2 (2)
Pain 8 (9) 4 (4)
Pelvis or perineum 1 (1) 0 (0)
Lower abdomen 3 (3) 2 (2)
Other abdominal pain 3 (3) 1 (1)
Acute pain 0 (0) 1 (1)
Urinary retention, dysuria and other urinary symptoms 0 (0) 0 (0)
Sling-specific complications 0 (0) 0 (0)
Perineal laceration during delivery 3 (3)
Grade I 2 (2)
Grade II 1 (1)
Grade III and IV 0 (0)
Int Urogynecol J
indication for cesarean section, according to our and previous
data [10, 11], vaginal delivery does not affect MUS results,
and thus the mode of delivery should be decided by obstetric
indications.
The main strength of our study is the comprehensive
national compulsory health care registries. These regis-
tries provide a relatively large population-based sample
without a selection bias. Another strength is the ability
to identify exact time points of the SUI re-procedures
and re-visits and assess only those that occurred after
the delivery subsequent to the index MUS. We were also
able to identify all the health care visits during the preg-
nancy after MUS and post-partum. The long follow-up
time can be considered a strength as well.
As a limitation in our study, we acknowledge that we
were unable to detect recurrent SUI and other complica-
tions unless the women decided to seek help from a doc-
tor. Using SUI re-procedures as the main end point also
produced only few end point events, which resulted in a
wide confidence interval and small power. However, we
consider re-visits and particularly re-procedures as robust
end points, because they are not subject to recall bias, for
example, and they reflect clinically relevant rates of SUI
recurrence well. Unfortunately, we were unable to match
the cases and controls according to their preoperative par-
ity. However, parity was not a significant risk factor for a
SUI re-procedure in our data, and other studies also show
conflicting results [10, 11]. We were also unable to report
the BMI at the time of the index MUS; however, there
was no significant difference in BMI between the cases
and controls at the beginning of the last pregnancy before
the index operation. We also acknowledge that we were
unable to determine the indication for postoperative cesar-
ean delivery; however, we were able to identify the pre-
vious delivery method as a reference point and identify
elective cesarean sections, which could be more likely
chosen because of a previous MUS operation than urgent
and crash cesarean sections. We were also unable to as-
sess if the complications during pregnancy and post-
partum were MUS-related, but the overall number of com-
plication visits was low. Even though SUI re-procedure is
a reliable main end point, it produced only few events;
thus, our study was under-powered to analyze other risk
factors than subsequent pregnancy.
To conclude, our data show that in women with a pre-
vious MUS operation, pregnancy and delivery do not in-
crease the odds for SUI re-procedure or an incontinence-
related re-visit. Furthermore, previous MUS operation
does not increase the rate of MUS-related complications
during pregnancy, delivery or post-partum. Thus, our re-
sults suggest that future pregnancy plans do not need to
be considered as an absolute contraindication for MUS
operation.
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